DOX vs. EPAM, CTSH, AZPN, HCP, VRSN, ZS, WIT, CYBR, TOST, and ZG
Should you be buying Amdocs stock or one of its competitors? The main competitors of Amdocs include EPAM Systems (EPAM), Cognizant Technology Solutions (CTSH), Aspen Technology (AZPN), HashiCorp (HCP), VeriSign (VRSN), Zscaler (ZS), Wipro (WIT), CyberArk Software (CYBR), Toast (TOST), and Zillow Group (ZG). These companies are all part of the "computer and technology" sector.
Amdocs (NASDAQ:DOX) and EPAM Systems (NYSE:EPAM) are both large-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, community ranking, dividends, profitability and analyst recommendations.
Amdocs received 23 more outperform votes than EPAM Systems when rated by MarketBeat users. However, 73.84% of users gave EPAM Systems an outperform vote while only 72.47% of users gave Amdocs an outperform vote.
Amdocs has higher revenue and earnings than EPAM Systems. Amdocs is trading at a lower price-to-earnings ratio than EPAM Systems, indicating that it is currently the more affordable of the two stocks.
Amdocs has a net margin of 11.30% compared to EPAM Systems' net margin of 8.89%. Amdocs' return on equity of 17.79% beat EPAM Systems' return on equity.
In the previous week, EPAM Systems had 11 more articles in the media than Amdocs. MarketBeat recorded 19 mentions for EPAM Systems and 8 mentions for Amdocs. Amdocs' average media sentiment score of 0.85 beat EPAM Systems' score of 0.54 indicating that Amdocs is being referred to more favorably in the media.
92.0% of Amdocs shares are held by institutional investors. Comparatively, 91.6% of EPAM Systems shares are held by institutional investors. 15.4% of Amdocs shares are held by insiders. Comparatively, 4.3% of EPAM Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Amdocs has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, EPAM Systems has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500.
Amdocs presently has a consensus target price of $108.60, suggesting a potential upside of 26.91%. EPAM Systems has a consensus target price of $323.93, suggesting a potential upside of 36.25%. Given EPAM Systems' higher possible upside, analysts clearly believe EPAM Systems is more favorable than Amdocs.
Summary
Amdocs and EPAM Systems tied by winning 9 of the 18 factors compared between the two stocks.
Get Amdocs News Delivered to You Automatically
Sign up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
